PKA signaling modulates PRMT5/hnRNP A1-mediated IRES translation and dictates responses to mTOR inhibition in glioblastoma. [PDF]
Kumar S +4 more
europepmc +1 more source
The Application of PD-1 Inhibitors in Immunotherapy for Glioblastoma. [PDF]
Dong MZ, Cui M, Qu LZ, Che HY, Guan HJ.
europepmc +1 more source
Anti-GBM pulmonary-renal syndrome: when the laboratory makes the difference. [PDF]
Frías Ruiz C, Martín Martínez MD.
europepmc +1 more source
The multiple autoantibodies in anti-GBM disease. [PDF]
Prendecki M, Pusey CD.
europepmc +1 more source
Non-diabetic kidney disease in a patient with type 2 diabetes mellitus: a case report. [PDF]
Jordanova E +5 more
europepmc +1 more source
Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager. [PDF]
Choi MJ +9 more
europepmc +1 more source
Fe<sup>3+</sup>-based nanovesicle mediated transferrin hijacking for glioblastoma stem cell tumoricidal treatment and postoperative recurrence inhibition. [PDF]
Liang F +7 more
europepmc +1 more source
Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy. [PDF]
Albelal D +5 more
europepmc +1 more source
AATF supports proliferation of glioblastoma cells by sustaining mitochondrial respiration through an NRF-1-dependent mechanism. [PDF]
Sorino C +15 more
europepmc +1 more source
[Rapidly progressive glomerulonephritis and ANCA--anti-GBM antibody].
openaire +1 more source

